Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients

Ther Adv Respir Dis. 2020 Jan-Dec:14:1753466620933510. doi: 10.1177/1753466620933510.

Authors

Raj Parikh¹, Carolyn Wilson², Janice Weinberg³, Daniel Gavin⁴, James Murphy⁴, Christine C Reardon⁴

Affiliations

¹ Division of Pulmonary and Critical Care, Boston University School of Medicine, 72 E Concord St R304, Boston, MA 02218, USA.
² Boston University School of Medicine, Boston, MA, USA.
³ Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
⁴ Division of Pulmonary and Critical Care, Boston University School of Medicine, Boston, MA, USA.

No abstract available

Publication types

Letter

MeSH terms

Administration, Inhalation
Betacoronavirus*
COVID-19
Coronavirus Infections / drug therapy*
Coronavirus Infections / physiopathology
Endothelium-Dependent Relaxing Factors / administration & dosage
Female
Humans
Male
Middle Aged
Nitric Oxide / administration & dosage*
Pandemics
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / physiopathology
Respiration
SARS-CoV-2
Treatment Outcome

Substances

Endothelium-Dependent Relaxing Factors
Nitric Oxide